See more : Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Ignyte Acquisition Corp. (IGNYW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ignyte Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Bunka Shutter Co., Ltd. (5930.T) Income Statement Analysis – Financial Results
- Flow Capital Corp. (AHFCF) Income Statement Analysis – Financial Results
- Primary Health Properties PLC (PHP.L) Income Statement Analysis – Financial Results
- 4Sight Holdings Limited (4SI.JO) Income Statement Analysis – Financial Results
- EPR Properties (EPR-PG) Income Statement Analysis – Financial Results
Ignyte Acquisition Corp. (IGNYW)
Industry: Shell Companies
Sector: Financial Services
About Ignyte Acquisition Corp.
Ignyte Acquisition Corp. intends enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in New York, New York.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 607.68K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 969.29K | 0.00 |
| Gross Profit | 607.68K | -969.29K | 0.00 |
| Gross Profit Ratio | 100.00% | 0.00% | 0.00% |
| Research & Development | 3.92M | 0.00 | 0.00 |
| General & Administrative | 8.53M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 8.53M | 0.00 | 0.00 |
| Other Expenses | 0.00 | -969.29K | 0.00 |
| Operating Expenses | 12.46M | -969.29K | 0.00 |
| Cost & Expenses | 12.46M | -969.29K | 0.00 |
| Interest Income | 2.11K | 0.00 | 0.00 |
| Interest Expense | -47.96K | -481.30K | 0.00 |
| Depreciation & Amortization | 1.21M | 481.30K | 206.30K |
| EBITDA | -11.85M | -487.99K | 0.00 |
| EBITDA Ratio | -1,949.68% | 0.00% | 0.00% |
| Operating Income | -13.06M | -969.29K | 0.00 |
| Operating Income Ratio | -2,149.59% | 0.00% | 0.00% |
| Total Other Income/Expenses | -100.04K | 481.30K | 0.00 |
| Income Before Tax | -13.16M | -487.99K | 0.00 |
| Income Before Tax Ratio | -2,166.06% | 0.00% | 0.00% |
| Income Tax Expense | 74.00K | -481.30K | 0.00 |
| Net Income | -13.24M | -6.69K | 0.00 |
| Net Income Ratio | -2,178.23% | 0.00% | 0.00% |
| EPS | -0.75 | 0.00 | 0.00 |
| EPS Diluted | -0.75 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 17.71M | 7.29M | 7.29M |
| Weighted Avg Shares Out (Dil) | 17.71M | 7.29M | 7.29M |
Source: https://incomestatements.info
Category: Stock Reports